Education

The Allegheny General Hospital (AGH) Department of Pharmacy offers the following postgraduate year one (PGY1 ) and postgraduate year two (PGY2) pharmacy residency programs that provide residents with the skills and knowledge required to become competent pharmacy practitioners:

• PGY1 Pharmacy Residency Program
• PGY2 Pharmacy Critical Care Residency Program
• PGY2 Pharmacy Oncology Residency Program
• PGY2 Pharmacy Ambulatory Care Residency Program

Each of the following programs is a 12-month (July 1 to June 30) postgraduate training experience composed of a variety of required and elective rotations tailored for each resident:

• PGY1 Pharmacy Residency Program - This program was first accredited by the American Society of Health-System Pharmacists (ASHP) in 1980 and most recently reaccredited in 2008. The program provides comprehensive training in all aspects of institutional practice with an emphasis on the delivery of pharmaceutical care and clinical services. The goal of the program is to develop the knowledge, skills, and philosophy required to pursue rational pharmacotherapy in a collaborative environment.

   

• PGY2 Pharmacy Critical Care Residency Program - This program was established in 1996 and most recently reaccredited by ASHP in 2008. The program emphasizes the integrated approach to the application of advanced clinical skills. The goal of the is to refine the knowledge, skills, and attitudes required to pursue rational pharmacotherapy in a collaborative environment for a critically ill patient population.

   

• PGY2 Pharmacy Oncology Residency Program - This program was established in 2007 and is pending accreditation. The program provides an environment to enhance pharmacotherapy skills in a variety of inpatient and outpatient settings through a health system with strength in hematological and oncological disorders. The primary objective of the program is to build problem-solving skills to enable practice in a multitude of clinical environments. Another goal is to provide the educational background for a PY2 resident to eventually become a board-certified oncology pharmacist (BCOP).

   

• PGY2 Pharmacy Ambulatory Care Residency Program - This program focuses on the outpatient experience and exposure to diverse populations (clinical, social, and economic). The resident will gain experience in management of chronic disease states (such as diabetes, heart failure, pulmonary hypertension, HIV, and anticoagulation). The goal of the program is to expand the resident’s ability to practice in the ambulatory setting, both independently and in collaboration with many different healthcare providers. The program was established in 2010. This program is not yet accredited by ASHP.